Revvity Inc
(BSP:R1VT34)
R$
23.77
0 (0%)
Market Cap: 81.00 Bil
Enterprise Value: 93.46 Bil
PE Ratio: 56.19
PB Ratio: 1.79
GF Score: 65/100 Revvity Inc at TD Cowen Health Care Conference Transcript
Mar 04, 2024 / 02:10PM GMT
Release Date Price:
R$19.54
Daniel Gregory Brennan
TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst
(technical difficulty) So I'm Dan Brennan, (technical difficulty) Prahlad Singh, President and CEO of Revvity. So Prahlad, welcome.
Prahlad R. Singh
Revvity, Inc. - CEO, President & Director
Thank you.
Daniel Gregory Brennan
TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst
And thanks for coming. Listen, I will check my e-mail a couple of times throughout if any of you want to pose any questions. I'll see if I can weave those in. We have a list and a little over 30 minutes to tackle it.
Questions & Answers
Daniel Gregory Brennan
TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst
So maybe I thought just to kick it off, obviously, the long-term guide. You guys just took it down from 10% to 6% to 8%. You've got 75 to 100 basis points of EBIT expansion. You kind of tweaked that down to 75 basis points, still
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot